Stem Cell Therapy to Treat Heart Failure

Comprehensive Biotechnology, Second Edition

Volumn 5, Issue , 2011, Pages 407-423

  Foldes G ^a,b   Harding, S E ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Cardiac regeneration; Cardiovascular disease; Cell based therapy; Clinical trials; Heart failure; Myocardial infarction; Stem cells

Indexed keywords

EID: 85012834959     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-08-088504-9.00157-4     Document Type: Chapter

References (271)

1. Lau D., Ogbogu U., Taylor B., et al. Stem cell clinics online: The direct-to-consumer portrayal of stem cell medicine. Cell Stem Cell 2008, 3:591-594.
2. Hansson E.M., Lindsay M.E., Chien K.R. Regeneration next: Toward heart stem cell therapeutics. Cell Stem Cell 2009, 5:364-377.
3. Lopez A.D., Mathers C.D., Ezzati M., et al. Global and regional burden of disease and risk factors, 2001: Systematic analysis of population health data. Lancet 2006, 367:1747-1757.
4. Heart disease statistics (2007). (accessed October 2010). http://fadelibrary.wordpress.com/2007/11/17/heart-disease-statistics/.
5. Levy D., Kenchaiah S., Larson M.G., et al. Long-term trends in the incidence of and survival with heart failure. New England Journal of Medicine 2002, 347:1397-1402.
6. Roger V.L., Weston S.A., Redfield M.M., et al. Trends in heart failure incidence and survival in a community-based population. Journal of the American Medical Association 2004, 292:344-350.
7. Stewart S., MacIntyre K., Capewell S., McMurray J.J. Heart failure and the aging population: An increasing burden in the 21st century?. Heart 2003, 89:49-53.
8. Weir R.A., McMurray J.J. Epidemiology of heart failure and left ventricular dysfunction after acute myocardial infarction. Current Heart Failure Reports 2006, 3:175-180.
9. McMurray J.J., Pfeffer M.A. Heart failure. Lancet 2005, 365:1877-1889.
10. Gheorghiade M., Bonow R.O. Chronic heart failure in the United States: A manifestation of coronary artery disease. Circulation 1998, 97:282-289.
11. Diwan A., Dorn G.W. Decompensation of cardiac hypertrophy: Cellular mechanisms and novel therapeutic targets. Physiology (Bethesda) 2007, 22:56-64.
12. Wang J., Nagueh S.F. Current perspectives on cardiac function in patients with diastolic heart failure. Circulation 2009, 119:1146-1157.
13. Bristow M.R., Saxon L.A., Boehmer J., et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. New England Journal of Medicine 2004, 350:2140-2150.
14. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. New England Journal of Medicine 2005, 352:225-237.
15. Rose E.A., Gelijns A.C., Moskowitz A.J., et al. Long-term mechanical left ventricular assistance for end-stage heart failure. New England Journal of Medicine 2001, 345:1435-1443.
16. Copeland J.G., Smith R.G., Arabia F.A., et al. Cardiac replacement with a total artificial heart as a bridge to transplantation. New England Journal of Medicine 2004, 351:859-867.
17. Wollert K.C., Drexler H. Cell-based therapy for heart failure. Current Opinion in Cardiology 2006, 21:234-239.
18. Rubart M., Field L.J. Cardiac regeneration: Repopulating the heart. Annual Review of Physiology 2006, 68:29-49.
19. Borchardt T., Braun T. Cardiovascular regeneration in non-mammalian model systems: What are the differences between newts and man?. Journal of Thrombosis and Haemostasis 2007, 98:311-318.
20. Lepilina A., Coon A.N., Kikuchi K., et al. A dynamic epicardial injury response supports progenitor cell activity during zebrafish heart regeneration. Cell 2006, 127:607-619.
21. Wagers A.J., Conboy I.M. Cellular and molecular signatures of muscle regeneration: Current concepts and controversies in adult myogenesis. Cell 2005, 122:659-667.
22. Shi X., Garry D.J. Muscle stem cells in development, regeneration, and disease. Genes and Development 2006, 20:1692-1708.
23. Bergmann O., Bhardwaj R.D., Bernard S., et al. Evidence for cardiomyocyte renewal in humans. Science 2009, 324:98-102.
24. Beltrami A.P., Barlucchi L., Torella D., et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003, 114:763-776.
25. + cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 2005, 433:647-653.
26. Martin C.M., Meeson A.P., Robertson S.M., et al. Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. Developmental Biology 2004, 265:262-275.
27. Oh H., Bradfute S.B., Gallardo T.D., et al. Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:12313-12318.
28. Hsieh P.C., Segers V.F., Davis M.E., et al. Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nature Medicine 2007, 13:970-974.
29. Quaini F., Urbanek K., Beltrami A.P., et al. Chimerism of the transplanted heart. New England Journal of Medicine 2002, 346:5-15.
30. Bayes-Genis A., Roura S., Prat-Vidal C., et al. Chimerism and microchimerism of the human heart: Evidence for cardiac regeneration. Nature Clinical Practice Cardiovascular Medicine 2007, 4(supplement 1):S40-S45.
31. Bianchi D.W., Johnson K.L., Salem D. Chimerism of the transplanted heart. New England Journal of Medicine 2002, 346:1410-1412.
32. Deb A., Wang S., Skelding K.A., et al. Bone marrow-derived cardiomyocytes are present in adult human heart: A study of gender-mismatched bone marrow transplantation patients. Circulation 2003, 107:1247-1249.
33. Segers V.F., Lee R.T. Stem-cell therapy for cardiac disease. Nature 2008, 451:937-942.
34. Chien K.R. Lost and found: Cardiac stem cell therapy revisited. Journal of Clinical Investigation 2006, 116:1838-1840.
35. Mathur A., Martin J.F. Stem cells and repair of the heart. Lancet 2004, 364:183-192.
36. Daley G.Q., Scadden D.T. Prospects for stem cell-based therapy. Cell 2008, 132:544-548.
37. Passier R., van Laake L.W., Mummery C.L. Stem-cell-based therapy and lessons from the heart. Nature 2008, 453:322-329.
38. Wollert K.C., Drexler H. Clinical applications of stem cells for the heart. Circulation Research 2005, 96:151-163.
39. Kocher A.A., Schuster M.D., Szabolcs M.J., et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nature Medicine 2001, 7:430-436.
40. Orlic D., Kajstura J., Chimenti S., et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001, 410:701-705.
41. Ishikawa F., Shimazu H., Shultz L.D., et al. Purified human hematopoietic stem cells contribute to the generation of cardiomyocytes through cell fusion. FASEB Journal 2006, 20:950-952.
42. Zhang S., Wang D., Estrov Z., et al. Both cell fusion and transdifferentiation account for the transformation of human peripheral blood CD34-positive cells into cardiomyocytes in vivo. Circulation 2004, 110:3803-3807.
43. Pauwelyn K.A., Verfaillie C.M. Transplantation of undifferentiated, bone marrow-derived stem cells. Current Topics in Developmental Biology 2006, 74:201-251.
44. Murry C.E., Soonpaa M.H., Reinecke H., et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004, 428:664-668.
45. Balsam L.B., Wagers A.J., Christensen J.L., et al. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004, 428:668-673.
46. Nygren J.M., Jovinge S., Breitbach M., et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nature Medicine 2004, 10:494-501.
47. Drexler H., Wollert K.C. Stem cells: Bone marrow cell therapy for MI-goal achieved?. Nature Reviews. Cardiology 2009, 6:615-616.
48. Gnecchi M., Zhang Z., Ni A., Dzau V.J. Paracrine mechanisms in adult stem cell signaling and therapy. Circulation Research 2008, 103:1204-1219.
49. Forrester J.S., White A.J., Matsushita S., et al. New paradigms of myocardial regeneration post-infarction: Tissue preservation, cell environment, and pluripotent cell sources. JACC: Cardiovascular Interventions 2009, 2:1-8.
50. + cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. Journal of Clinical Investigations 2006, 116:1865-1877.
51. Diwan A., Krenz M., Syed F.M., et al. Inhibition of ischemic cardiomyocyte apoptosis through targeted ablation of Bnip3 restrains postinfarction remodeling in mice. Journal of Clinical Investigations 2007, 117:2825-2833.
52. Kamihata H., Matsubara H., Nishiue T., et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 2001, 104:1046-1052.
53. Waksman R., Fournadjiev J., Baffour R., et al. Transepicardial autologous bone marrow-derived mononuclear cell therapy in a porcine model of chronically infarcted myocardium. Cardiovascular Radiation Medicine 2004, 5:125-131.
54. Papayannopoulou T., Scadden D.T. Stem-cell ecology and stem cells in motion. Blood 2008, 111:3923-3930.
55. Yoshioka T., Ageyama N., Shibata H., et al. Repair of infarcted myocardium mediated by transplanted bone marrow-derived CD34+ stem cells in a nonhuman primate model. Stem Cells 2005, 23:355-364.
56. Limbourg F.P., Ringes-Lichtenberg S., Schaefer A., et al. Haematopoietic stem cells improve cardiac function after infarction without permanent cardiac engraftment. European Journal of Heart Failure 2005, 7:722-729.
57. Amsalem Y., Mardor Y., Feinberg M.S., et al. Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium. Circulation 2007, 116:I38-I45.
58. Korf-Klingebiel M., Kempf T., Sauer T., et al. Bone marrow cells are a rich source of growth factors and cytokines: Implications for cell therapy trials after myocardial infarction. European Heart Journal 2008, 29:2851-2858.
59. Kupatt C., Horstkotte J., Vlastos G.A., et al. Embryonic endothelial progenitor cells expressing a broad range of proangiogenic and remodeling factors enhance vascularization and tissue recovery in acute and chronic ischemia. FASEB Journal 2005, 19:1576-1578.
60. Uemura R., Xu M., Ahmad N., Ashraf M. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circulation Research 2006, 98:1414-1421.
61. Hinkel R., El-Aouni C., Olson T., et al. Thymosin beta4 is an essential paracrine factor of embryonic endothelial progenitor cell-mediated cardioprotection. Circulation 2008, 117:2232-2240.
62. Mirotsou M., Zhang Z., Deb A., et al. Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:1643-1648.
63. Alfaro M.P., Pagni M., Vincent A., et al. The Wnt modulator sFRP2 enhances mesenchymal stem cell engraftment, granulation tissue formation and myocardial repair. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:18366-18371.
64. Hofmann M., Wollert K.C., Meyer G.P., et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 2005, 111:2198-2202.
65. Haider H.K., Jiang S., Idris N.M., Ashraf M. IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1alpha/CXCR4 signaling to promote myocardial repair. Circulation Research 2008, 103:1300-1308.
66. Mangi A.A., Noiseux N., Kong D., et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nature Medicine 2003, 9:1195-1201.
67. Dai W., Wold L.E., Dow J.S., Kloner R.A. Thickening of the infarcted wall by collagen injection improves left ventricular function in rats: A novel approach to preserve cardiac function after myocardial infarction. Journal of the American College of Cardiology 2005, 46:714-719.
68. Alhadlaq A., Mao J.J. Mesenchymal stem cells: Isolation and therapeutics. Stem Cells and Development 2004, 13:436-448.
69. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
70. Jiang Y., Jahagirdar B.N., Reinhardt R.L., et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002, 418:41-49.
71. Makino S., Fukuda K., Miyoshi S., et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. Journal of Clinical Investigations 1999, 103:697-705.
72. Mazhari R., Hare J.M. Mechanisms of action of mesenchymal stem cells in cardiac repair: Potential influences on the cardiac stem cell niche. Nature Clinical Practice Cardiovascular Medicine 2007, 4(supplement 1):S21-S26.
73. Schuleri K.H., Amado L.C., Boyle A.J., et al. Early improvement in cardiac tissue perfusion due to mesenchymal stem cells. American Journal of Physiology-Heart and Circulatory Physiology 2008, 294:H2002-H2011.
74. Toma C., Pittenger M.F., Cahill K.S., et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002, 105:93-98.
75. Planat-Benard V., Menard C., Andre M., et al. Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circulation Research 2004, 94:223-229.
76. Miyahara Y., Nagaya N., Kataoka M., et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nature Medicine 2006, 12:459-465.
77. Silva G.V., Litovsky S., Assad J.A., et al. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 2005, 111:150-156.
78. Noiseux N., Gnecchi M., Lopez-Ilasaca M., et al. Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Molecular Therapy 2006, 14:840-850.
79. Rose R.A., Jiang H., Wang X., et al. Bone marrow-derived mesenchymal stromal cells express cardiac-specific markers, retain the stromal phenotype, and do not become functional cardiomyocytes in vitro. Stem Cells 2008, 26:2884-2892.
80. Liechty K.W., MacKenzie T.C., Shaaban A.F., et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nature Medicine 2000, 6:1282-1286.
81. Amado L.C., Saliaris A.P., Schuleri K.H., et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:11474-11479.
82. Aggarwal S., Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005, 105:1815-1822.
83. Dai W., Hale S.L., Martin B.J., et al. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: Short- and long-term effects. Circulation 2005, 112:214-223.
84. Gnecchi M., He H., Liang O.D., et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nature Medicine 2005, 11:367-368.
85. Caplan A.I., Dennis J.E. Mesenchymal stem cells as trophic mediators. Journal of Cellular Biochemistry 2006, 98:1076-1084.
86. Chen S.L., Fang W.W., Ye F., et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. American Journal of Cardiology 2004, 94:92-95.
87. Hare J.M., Traverse J.H., Henry T.D., et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. Journal of the American College of Cardiology 2009, 54:2277-2286.
88. Yoon Y.S., Park J.S., Tkebuchava T., et al. Unexpected severe calcification after transplantation of bone marrow cells in acute myocardial infarction. Circulation 2004, 109:3154-3157.
89. Breitbach M., Bostani T., Roell W., et al. Potential risks of bone marrow cell transplantation into infarcted hearts. Blood 2007, 110:1362-1369.
90. Young P.P., Vaughan D.E., Hatzopoulos A.K. Biologic properties of endothelial progenitor cells and their potential for cell therapy. Progress in Cardiovascular Disease 2007, 49:421-429.
91. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
92. Purhonen S., Palm J., Rossi D., et al. Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:6620-6625.
93. Yoder M.C., Mead L.E., Prater D., et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007, 109:1801-1809.
94. Gill M., Dias S., Hattori K., et al. Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circulation Research 2001, 88:167-174.
95. Kalka C., Tehrani H., Laudenberg B., et al. VEGF gene transfer mobilizes endothelial progenitor cells in patients with inoperable coronary disease. Annals of Thoracic Surgery 2000, 70:829-834.
96. Fukuhara S., Tomita S., Nakatani T., et al. G-CSF promotes bone marrow cells to migrate into infarcted mice heart, and differentiate into cardiomyocytes. Cell Transplant 2004, 13:741-748.
97. Llevadot J., Murasawa S., Kureishi Y., et al. HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. Journal of Clinical Investigations 2001, 108:399-405.
98. Kureishi Y., Luo Z., Shiojima I., et al. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nature Medicine 2000, 6:1004-1010.
99. Crosby J.R., Kaminski W.E., Schatteman G., et al. Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. Circulation Research 2000, 87:728-730.
100. Shi Q., Rafii S., Wu M.H., et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998, 92:362-367.
101. Iwasaki H., Kawamoto A., Ishikawa M., et al. Dose-dependent contribution of CD34-positive cell transplantation to concurrent vasculogenesis and cardiomyogenesis for functional regenerative recovery after myocardial infarction. Circulation 2006, 113:1311-1325.
102. Jujo K., Ii M., Losordo D.W. Endothelial progenitor cells in neovascularization of infarcted myocardium. Journal of Molecular and Cellular Cardiology 2008, 45:530-544.
103. Vasa M., Fichtlscherer S., Aicher A., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circulation Research 2001, 89:E1-E7.
104. Imanishi T., Moriwaki C., Hano T., Nishio I. Endothelial progenitor cell senescence is accelerated in both experimental hypertensive rats and patients with essential hypertension. Journal of Hypertension 2005, 23:1831-1837.
105. Stamm C., Kleine H.D., Choi Y.H., et al. Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: Safety and efficacy studies. Journal of Thoracic and Cardiovascular Surgery 2007, 133:717-725.
106. Losordo D.W., Schatz R.A., White C.J., et al. Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: A phase I/IIa double-blind, randomized controlled trial. Circulation 2007, 115:3165-3172.
107. Bartunek J., Vanderheyden M., Vandekerckhove B., et al. Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: Feasibility and safety. Circulation 2005, 112:I178-I183.
108. Kawamoto A., Tkebuchava T., Yamaguchi J., et al. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 2003, 107:461-468.
109. Erbs S., Linke A., Adams V., et al. Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: First randomized and placebo-controlled study. Circulation Research 2005, 97:756-762.
110. Stamm C., Westphal B., Kleine H.D., et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 2003, 361:45-46.
111. Leone A.M., Rutella S., Bonanno G., et al. Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function. European Heart Journal 2005, 26:1196-1204.
112. Aoki J., Serruys P.W., van Beusekom H., et al. Endothelial progenitor cell capture by stents coated with antibody against CD34: The HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First in Man) registry. Journal of the American College of Cardiology 2005, 45:1574-1579.
113. Buckingham M., Montarras D. Skeletal muscle stem cells. Current Opinion in Genetics and Development 2008, 18:330-336.
114. Murry C.E., Wiseman R.W., Schwartz S.M., Hauschka S.D. Skeletal myoblast transplantation for repair of myocardial necrosis. Journal of Clinical Investigations 1996, 98:2512-2523.
115. Pagani F.D., DerSimonian H., Zawadzka A., et al. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. Journal of the American College of Cardiology 2003, 41:879-888.
116. Asakura A., Komaki M., Rudnicki M. Muscle satellite cells are multipotential stem cells that exhibit myogenic, osteogenic, and adipogenic differentiation. Differentiation 2001, 68:245-253.
117. Taylor D.A., Atkins B.Z., Hungspreugs P., et al. Regenerating functional myocardium: Improved performance after skeletal myoblast transplantation. Nature Medicine 1998, 4:929-933.
118. Ghostine S., Carrion C., Souza L.C., et al. Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction. Circulation 2002, 106:I131-I136.
119. Farahmand P., Lai T.Y., Weisel R.D., et al. Skeletal myoblasts preserve remote matrix architecture and global function when implanted early or late after coronary ligation into infarcted or remote myocardium. Circulation 2008, 118:S130-S137.
120. Siminiak T., Fiszer D., Jerzykowska O., et al. Percutaneous trans-coronary-venous transplantation of autologous skeletal myoblasts in the treatment of post-infarction myocardial contractility impairment: The POZNAN trial. European Heart Journal 2005, 26:1188-1195.
121. Leobon B., Garcin I., Menasche P., et al. Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:7808-7811.
122. Reinecke H., Poppa V., Murry C.E. Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. Journal of Molecular and Cellular Cardiology 2002, 34:241-249.
123. Menasche P. Stem cell therapy for heart failure: Are arrhythmias a real safety concern?. Circulation 2009, 119:2735-2740.
124. Abraham M.R., Henrikson C.A., Tung L., et al. Antiarrhythmic engineering of skeletal myoblasts for cardiac transplantation. Circulation Research 2005, 97:159-167.
125. Roell W., Lewalter T., Sasse P., et al. Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia. Nature 2007, 450:819-824.
126. Suzuki K., Murtuza B., Beauchamp J.R., et al. Dynamics and mediators of acute graft attrition after myoblast transplantation to the heart. FASEB Journal 2004, 18:1153-1155.
127. Menasche P., Hagege A.A., Vilquin J.T., et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. Journal of the American College of Cardiology 2003, 41:1078-1083.
128. Herreros J., Prosper F., Perez A., et al. Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. European Heart Journal 2003, 24:2012-2020.
129. Smits P.C., van Geuns R.J., Poldermans D., et al. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: Clinical experience with six-month follow-up. Journal of the American College of Cardiology 2003, 42:2063-2069.
130. Dib N., McCarthy P., Campbell A., et al. Feasibility and safety of autologous myoblast transplantation in patients with ischemic cardiomyopathy. Cell Transplantation 2005, 14:11-19.
131. Menasche P., Alfieri O., Janssens S., et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: First randomized placebo-controlled study of myoblast transplantation. Circulation 2008, 117:1189-1200.
132. Fouts K., Fernandes B., Mal N., et al. Electrophysiological consequence of skeletal myoblast transplantation in normal and infarcted canine myocardium. Heart Rhythm 2006, 3:452-461.
133. Fernandes S., Amirault J.C., Lande G., et al. Autologous myoblast transplantation after myocardial infarction increases the inducibility of ventricular arrhythmias. Cardiovascular Research 2006, 69:348-358.
134. Itabashi Y., Miyoshi S., Yuasa S., et al. Analysis of the electrophysiological properties and arrhythmias in directly contacted skeletal and cardiac muscle cell sheets. Cardiovascular Research 2005, 67:561-570.
135. Hagege A.A., Carrion C., Menasche P., et al. Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy. Lancet 2003, 361:491-492.
136. Cleland J.G., Coletta A.P., Abdellah A.T., et al. Clinical trials update from the American Heart Association 2006: OAT, SALT 1 and 2, MAGIC, ABCD, PABA-CHF, IMPROVE-CHF, and percutaneous mitral annuloplasty. European Journal of Heart Failure 2007, 9:92-97.
137. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., et al. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
138. Kehat I., Kenyagin-Karsenti D., Snir M., et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. Journal of Clinical Investigations 2001, 108:407-414.
139. Ferreira L.S., Gerecht S., Shieh H.F., et al. Vascular progenitor cells isolated from human embryonic stem cells give rise to endothelial and smooth muscle like cells and form vascular networks in vivo. Circulation Research 2007, 101:286-294.
140. Levenberg S., Golub J.S., Amit M., et al. Endothelial cells derived from human embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:4391-4396.
141. Huang H., Zhao X., Chen L., et al. Differentiation of human embryonic stem cells into smooth muscle cells in adherent monolayer culture. Biochemical and Biophysical Research Communications 2006, 351:321-327.
142. Wang X., Wei G., Yu W., et al. Scalable producing embryoid bodies by rotary cell culture system and constructing engineered cardiac tissue with ES-derived cardiomyocytes in vitro. Biotechnology Progress 2006, 22:811-818.
143. Zandstra P.W., Bauwens C., Yin T., et al. Scalable production of embryonic stem cell-derived cardiomyocytes. Tissue Engineering 2003, 9:767-778.
144. Laflamme M.A., Chen K.Y., Naumova A.V., et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nature Biotechnology 2007, 25:1015-1024.
145. He J.Q., Ma Y., Lee Y., et al. Human embryonic stem cells develop into multiple types of cardiac myocytes: Action potential characterization. Circulation Research 2003, 93:32-39.
146. Xu C., Police S., Rao N., Carpenter M.K. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circulation Research 2002, 91:501-508.
147. Beqqali A., Kloots J., Ward-van Oostwaard D., et al. Genome-wide transcriptional profiling of human embryonic stem cells differentiating to cardiomyocytes. Stem Cells 2006, 24:1956-1967.
148. Passier R., Ward-van Oostwaard D., Snapper J., et al. Increased cardiomyocyte differentiation from human embryonic stem cells in serum-free cultures. Stem Cells 2005, 23:772-780.
149. Mummery C., Ward-van Oostwaard D., Doevendans P., et al. Differentiation of human embryonic stem cells to cardiomyocytes: Role of coculture with visceral endoderm-like cells. Circulation 2003, 107:2733-2740.
150. Cai J., Yi F.F., Yang X.C., et al. Transplantation of embryonic stem cell-derived cardiomyocytes improves cardiac function in infarcted rat hearts. Cytotherapy 2007, 9:283-291.
151. Kolossov E., Bostani T., Roell W., et al. Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium. Journal of Experimental Medicine 2006, 203:2315-2327.
152. Singla D.K., Lyons G.E., Kamp T.J. Transplanted embryonic stem cells following mouse myocardial infarction inhibit apoptosis and cardiac remodeling. American Journal of Physiology- Heart and Circulatory Physiology 2007, 293:H1308-H1314.
153. Caspi O., Huber I., Kehat I., et al. Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. Journal of the American College of Cardiology 2007, 50:1884-1893.
154. Hodgson D.M., Behfar A., Zingman L.V., et al. Stable benefit of embryonic stem cell therapy in myocardial infarction. American Journal of Physiology-Heart and Circulatory Physiology 2004, 287:H471-H479.
155. Yamada S., Nelson T.J., Crespo-Diaz R.J., et al. Embryonic stem cell therapy of heart failure in genetic cardiomyopathy. Stem Cells 2008, 26:2644-2653.
156. van Laake L.W., van Donselaar E.G., Monshouwer-Kloots J., et al. Extracellular matrix formation after transplantation of human embryonic stem cell-derived cardiomyocytes. Cellular and Molecular Life Sciences 2009, 67(2):277-290.
157. Roell W., Fan Y., Xia Y., et al. Cellular cardiomyoplasty in a transgenic mouse model. Transplantation 2002, 73:462-465.
158. van Laake L.W., Passier R., Monshouwer-Kloots J., et al. Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. Stem Cell Research 2007, 1:9-24.
159. Lu B., Malcuit C., Wang S., et al. Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration. Stem Cells 2009, 27:2126-2135.
160. Alper J. Geron gets green light for human trial of ES cell-derived product. Nature Biotechnology 2009, 27:213-214.
161. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
162. Park I.H., Zhao R., West J.A., et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008, 451:141-146.
163. Yu J., Vodyanik M.A., Smuga-Otto K., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.
164. Takahashi K., Tanabe K., Ohnuki M., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
165. Blelloch R., Venere M., Yen J., Ramalho-Santos M. Generation of induced pluripotent stem cells in the absence of drug selection. Cell Stem Cell 2007, 1:245-247.
166. Meissner A., Wernig M., Jaenisch R. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nature Biotechnology 2007, 25:1177-1181.
167. Kaji K., Norrby K., Paca A., et al. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 2009, 458:771-775.
168. Woltjen K., Michael I.P., Mohseni P., et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 2009, 458:766-770.
169. Yu J., Hu K., Smuga-Otto K., et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009, 324:797-801.
170. Kim D., Kim C.H., Moon J.I., et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 2009, 4:472-476.
171. Zhang J., Wilson G.F., Soerens A.G., et al. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circulation Research 2009, 104:e30-e41.
172. Park I.H., Arora N., Huo H., et al. Disease-specific induced pluripotent stem cells. Cell 2008, 134:877-886.
173. Fairchild P.J. Transplantation tolerance in an age of induced pluripotency. Current Opinion in Organ Transplantation 2009, 14:321-325.
174. Martin-Puig S., Wang Z., Chien K.R. Lives of a heart cell: Tracing the origins of cardiac progenitors. Cell Stem Cell 2008, 2:320-331.
175. Fuchs E., Tumbar T., Guasch G. Socializing with the neighbors: Stem cells and their niche. Cell 2004, 116:769-778.
176. Moore K.A., Lemischka I.R. Stem cells and their niches. Science 2006, 311:1880-1885.
177. Challen G.A., Little M.H. A side order of stem cells: The SP phenotype. Stem Cells 2006, 24:3-12.
178. Hierlihy A.M., Seale P., Lobe C.G., et al. The post-natal heart contains a myocardial stem cell population. FEBS Letters 2002, 530:239-243.
179. Oyama T., Nagai T., Wada H., et al. Cardiac side population cells have a potential to migrate and differentiate into cardiomyocytes in vitro and in vivo. Journal of Cell Biology 2007, 176:329-341.
180. Pfister O., Mouquet F., Jain M., et al. CD31-but not CD31+ cardiac side population cells exhibit functional cardiomyogenic differentiation. Circulation Research 2005, 97:52-61.
181. Mouquet F., Pfister O., Jain M., et al. Restoration of cardiac progenitor cells after myocardial infarction by self-proliferation and selective homing of bone marrow-derived stem cells. Circulation Research 2005, 97:1090-1092.
182. Wang X., Hu Q., Nakamura Y., et al. The role of the Sca-1+/CD31-cardiac progenitor cell population in postinfarction left ventricular remodeling. Stem Cells 2006, 24:1779-1788.
183. Massberg S., Schaerli P., Knezevic-Maramica I., et al. Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues. Cell 2007, 131:994-1008.
184. Wu S.M., Fujiwara Y., Cibulsky S.M., et al. Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart. Cell 2006, 127:1137-1150.
185. + progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 2006, 127:1151-1165.
186. Dawn B., Stein A.B., Urbanek K., et al. Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:3766-3771.
187. Messina E., De A.L., Frati G., et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circulation Research 2004, 95:911-921.
188. Smith R.R., Barile L., Cho H.C., et al. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 2007, 115:896-908.
189. van Vliet P., Roccio M., Smits A.M., et al. Progenitor cells isolated from the human heart: A potential cell source for regenerative therapy. Netherlands Heart Journal 2008, 16:163-169.
190. Takehara N., Tsutsumi Y., Tateishi K., et al. Controlled delivery of basic fibroblast growth factor promotes human cardiosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarction. Journal of the American College of Cardiology 2008, 52:1858-1865.
191. Winter E.M., Grauss R.W., Hogers B., et al. Preservation of left ventricular function and attenuation of remodeling after transplantation of human epicardium-derived cells into the infarcted mouse heart. Circulation 2007, 116:917-927.
192. Smart N., Risebro C.A., Melville A.A., et al. Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization. Nature 2007, 445:177-182.
193. Lunde K., Solheim S., Aakhus S., et al. Autologous stem cell transplantation in acute myocardial infarction: The ASTAMI randomized controlled trial. Intracoronary transplantation of autologous mononuclear bone marrow cells, study design and safety aspects. Scandinavian Cardiovascular Journal 2005, 39:150-158.
194. Arnesen H., Lunde K., Aakhus S., Forfang K. Cell therapy in myocardial infarction. Lancet 2007, 369:2142-2143.
195. Seeger F.H., Tonn T., Krzossok N., et al. Cell isolation procedures matter: A comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. European Heart Journal 2007, 28:766-772.
196. Welt F.G., Losordo D.W. Cell therapy for acute myocardial infarction: Curb your enthusiasm?. Circulation 2006, 113:1272-1274.
197. Barbash I.M., Chouraqui P., Baron J., et al. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: Feasibility, cell migration, and body distribution. Circulation 2003, 108:863-868.
198. Janssens S., Dubois C., Bogaert J., et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: Double-blind, randomised controlled trial. Lancet 2006, 367:113-121.
199. Perin E.C., Lopez J. Methods of stem cell delivery in cardiac diseases. Nature Clinical Practice Cardiovascular Medicine 2006, 3(supplement 1):S110-S113.
200. Tse H.F., Kwong Y.L., Chan J.K., et al. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 2003, 361:47-49.
201. Gyongyosi M., Lang I., Dettke M., et al. Combined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: The MYSTAR prospective, randomized study. Nature Clinical Practice Cardiovascular Medicine 2009, 6:70-81.
202. Sherman W., Martens T.P., Viles-Gonzalez J.F., Siminiak T. Catheter-based delivery of cells to the heart. Nature Clinical Practice Cardiovascular Medicine 2006, 3(supplement 1):S57-S64.
203. Raake P., von Degenfeld G., Hinkel R., et al. Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins: Comparison with surgical and percutaneous intramyocardial gene delivery. Journal of the American College of Cardiology 2004, 44:1124-1129.
204. Thompson C.A., Nasseri B.A., Makower J., et al. Percutaneous transvenous cellular cardiomyoplasty. A novel nonsurgical approach for myocardial cell transplantation. Journal of the American College of Cardiology 2003, 41:1964-1971.
205. Schachinger V., Aicher A., Dobert N., et al. Pilot trial on determinants of progenitor cell recruitment to the infarcted human myocardium. Circulation 2008, 118:1425-1432.
206. Terrovitis J., Kwok K.F., Lautamaki R., et al. Ectopic expression of the sodium-iodide symporter enables imaging of transplanted cardiac stem cells in vivo by single-photon emission computed tomography or positron emission tomography. Journal of the American College of Cardiology 2008, 52:1652-1660.
207. Wu J.C. Molecular imaging: Antidote to cardiac stem cell controversy. Journal of the American College of Cardiology 2008, 52:1661-1664.
208. Dimmeler S., Zeiher A.M., Schneider M.D. Unchain my heart: The scientific foundations of cardiac repair. Journal of Clinical Investigations 2005, 115:572-583.
209. Strauer B.E., Brehm M., Zeus T., et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002, 106:1913-1918.
210. Assmus B., Schachinger V., Teupe C., et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 2002, 106:3009-3017.
211. Lunde K., Solheim S., Aakhus S., et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. New England Journal of Medicine 2006, 355:1199-1209.
212. Schachinger V., Erbs S., Elsasser A., et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. New England Journal of Medicine 2006, 355:1210-1221.
213. Assmus B., Rolf A., Erbs S., et al. Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction. Circulation: Heart Failure 2010, 3:89-96.
214. Assmus B., Honold J., Schachinger V., et al. Transcoronary transplantation of progenitor cells after myocardial infarction. New England Journal of Medicine 2006, 355:1222-1232.
215. Tse H.F., Thambar S., Kwong Y.L., et al. Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial). European Heart Journal 2007, 28:2998-3005.
216. Yao K., Huang R., Qian J., et al. Administration of intracoronary bone marrow mononuclear cells on chronic myocardial infarction improves diastolic function. Heart 2008, 94:1147-1153.
217. Strauer B.E., Brehm M., Zeus T., et al. Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: The IACT study. Journal of the American College of Cardiology 2005, 46:1651-1658.
218. van Ramshorst J., Bax J.J., Beeres S.L., et al. Intramyocardial bone marrow cell injection for chronic myocardial ischemia: A randomized controlled trial. Journal of the American Medical Association 2009, 301:1997-2004.
219. Hristov M., Heussen N., Schober A., Weber C. Intracoronary infusion of autologous bone marrow cells and left ventricular function after acute myocardial infarction: A meta-analysis. Journal of Cellular and Molecular Medicine 2006, 10:727-733.
220. Lipinski M.J., Biondi-Zoccai G.G., Abbate A., et al. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: A collaborative systematic review and meta-analysis of controlled clinical trials. Journal of the American College of Cardiology 2007, 50:1761-1767.
221. Martin-Rendon E., Brunskill S.J., Hyde C.J., et al. Autologous bone marrow stem cells to treat acute myocardial infarction: A systematic review. European Heart Journal 2008, 29:1807-1818.
222. Abdel-Latif A., Bolli R., Tleyjeh I.M., et al. Adult bone marrow-derived cells for cardiac repair: A systematic review and meta-analysis. Archives of Internal Medicine 2007, 167:989-997.
223. Kang S., Yang Y.J., Li C.J., Gao R.L. Effects of intracoronary autologous bone marrow cells on left ventricular function in acute myocardial infarction: A systematic review and meta-analysis for randomized controlled trials. Coronary Artery Disease 2008, 19:327-335.
224. Tendera M., Wojakowski W., Ruzyllo W., et al. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: Results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) trial. European Heart Journal 2009, 30:1313-1321.
225. Wollert K.C., Meyer G.P., Lotz J., et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomised controlled clinical trial. Lancet 2004, 364:141-148.
226. Meyer G.P., Wollert K.C., Lotz J., et al. Intracoronary bone marrow cell transfer after myocardial infarction: Eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 2006, 113:1287-1294.
227. Meyer G.P., Wollert K.C., Lotz J., et al. Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial. European Heart Journal 2009, 30:2978-2984.
228. Abdulla J., Barlera S., Latini R., et al. A systematic review: Effect of angiotensin converting enzyme inhibition on left ventricular volumes and ejection fraction in patients with a myocardial infarction and in patients with left ventricular dysfunction. European Journal of Heart Failure 2007, 9:129-135.
229. Stone G.W., Grines C.L., Cox D.A., et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. New England Journal of Medicine 2002, 346:957-966.
230. Adler E.D., Maddox T.M. Cell therapy for cardiac disease: Where do we go from here?. Nature Clinical Practice Cardiovascular Medicine 2007, 4:2-3.
231. Lunde K., Solheim S., Aakhus S., et al. Exercise capacity and quality of life after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: Results from the Autologous Stem cell Transplantation in Acute Myocardial Infarction (ASTAMI) randomized controlled trial. American Heart Journal 2007, 154:710-718.
232. Cardiac cell therapy: Bench or bedside?. Nature Clinical Practice Cardiovascular Medicine 2007, 4:403. Steering Committee of the National Heart LaBICCTRN.
233. Bartunek J., Dimmeler S., Drexler H., et al. The consensus of the task force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for repair of the heart. European Heart Journal 2006, 27:1338-1340.
234. Martin J. Collaboration in cardiovascular stem-cell research. Lancet 2005, 365:2070-2071.
235. Menard C., Hagege A.A., Agbulut O., et al. Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: A preclinical study. Lancet 2005, 366:1005-1012.
236. Leor J., Gerecht S., Cohen S., et al. Human embryonic stem cell transplantation to repair the infarcted myocardium. Heart 2007, 93:1278-1284.
237. Meluzin J., Janousek S., Mayer J., et al. Three-, 6-, and 12-month results of autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction. International Journal of Cardiology 2008, 128:185-192.
238. Meluzin J., Mayer J., Groch L., et al. Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: The effect of the dose of transplanted cells on myocardial function. American Heart Journal 2006, 152:975. e9-975.e15.
239. Assmus B., Fischer-Rasokat U., Honold J., et al. Transcoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: Results of the TOPCARE-CHD registry. Circulation Research 2007, 100:1234-1241.
240. Schachinger V., Erbs S., Elsasser A., et al. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: Final 1-year results of the REPAIR-AMI trial. European Heart Journal 2006, 27:2775-2783.
241. Schachinger V., Erbs S., Elsasser A., et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. New England Journal of Medicine 2006, 355:1210-1221.
242. Ge J., Li Y., Qian J., et al. Efficacy of emergent transcatheter transplantation of stem cells for treatment of acute myocardial infarction (TCT-STAMI). Heart 2006, 92:1764-1767.
243. Hendrikx M., Hensen K., Clijsters C., et al. Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation: Results from a randomized controlled clinical trial. Circulation 2006, 114:I101-I107.
244. Mocini D., Staibano M., Mele L., et al. Autologous bone marrow mononuclear cell transplantation in patients undergoing coronary artery bypass grafting. American Heart Journal 2006, 151:192-197.
245. Perin E.C., Dohmann H.F., Borojevic R., et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 2003, 107:2294-2302.
246. Tatsumi T., Ashihara E., Yasui T., et al. Intracoronary transplantation of non-expanded peripheral blood-derived mononuclear cells promotes improvement of cardiac function in patients with acute myocardial infarction. Circulation Journal: Official Journal of the Japanese Circulation Society 2007, 71:1199-1207.
247. Choi J.H., Choi J., Lee W.S., et al. Lack of additional benefit of intracoronary transplantation of autologous peripheral blood stem cell in patients with acute myocardial infarction. Circulation Journal: Official Journal of the Japanese Circulation Society 2007, 71:486-494.
248. Kang H.J., Lee H.Y., Na S.H., et al. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: The MAGIC Cell-3-DES randomized, controlled trial. Circulation 2006, 114:I145-I151.
249. Li Z.Q., Zhang M., Jing Y.Z., et al. The clinical study of autologous peripheral blood stem cell transplantation by intracoronary infusion in patients with acute myocardial infarction (AMI). International Journal of Cardiology 2007, 115:52-56.
250. Ahmadi H., Baharvand H., Ashtiani S.K., et al. Safety analysis and improved cardiac function following local autologous transplantation of CD133(+) enriched bone marrow cells after myocardial infarction. Current Neurovascular Research 2007, 4:153-160.
251. Gavira J.J., Herreros J., Perez A., et al. Autologous skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1-year follow-up. Journal of Thoracic Cardiovascular Surgery 2006, 131:799-804.
252. Ince H., Petzsch M., Rehders T.C., et al. Transcatheter transplantation of autologous skeletal myoblasts in postinfarction patients with severe left ventricular dysfunction. Journal of Endovascular Therapy 2004, 11:695-704.
253. Chen S., Liu Z., Tian N., et al. Intracoronary transplantation of autologous bone marrow mesenchymal stem cells for ischemic cardiomyopathy due to isolated chronic occluded left anterior descending artery. Journal of Invasive Cardiology 2006, 18:552-556.
254. Katritsis D.G., Sotiropoulou P.A., Karvouni E., et al. Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium. Catheterization and Cardiovascular Interventions 2005, 65:321-329.
255. Ruan W., Pan C.Z., Huang G.Q., et al. Assessment of left ventricular segmental function after autologous bone marrow stem cells transplantation in patients with acute myocardial infarction by tissue tracking and strain imaging. Chinese Medical Journal (England) 2005, 118:1175-1181.
256. Kiuru M., Boyer J.L., O'Connor T.P., Crystal R.G. Genetic control of wayward pluripotent stem cells and their progeny after transplantation. Cell Stem Cell 2009, 4:289-300.
257. Liu J., Fu J.D., Siu C.W., Li R.A. Functional sarcoplasmic reticulum for calcium handling of human embryonic stem cell-derived cardiomyocytes: Insights for driven maturation. Stem Cells 2007, 25:3038-3044.
258. Reinecke H., Zhang M., Bartosek T., Murry C.E. Survival, integration, and differentiation of cardiomyocyte grafts: A study in normal and injured rat hearts. Circulation 1999, 100:193-202.
259. Kirouac D.C., Zandstra P.W. The systematic production of cells for cell therapies. Cell Stem Cell 2008, 3:369-381.
260. Puceat M., Ballis A. Embryonic stem cells: From bench to bedside. Clinical Pharmacology and Therapeutics 2007, 82:337-339.
261. Dimmeler S., Burchfield J., Zeiher A.M. Cell-based therapy of myocardial infarction. Arteriosclerosis, Thrombosis, and Vascular Biology 2008, 28:208-216.
262. Makkar R.R., Lill M., Chen P.S. Stem cell therapy for myocardial repair: Is it arrhythmogenic?. Journal of the American College of Cardiology 2003, 42:2070-2072.
263. Ly H.Q., Nattel S. Stem cells are not proarrhythmic: Letting the genie out of the bottle. Circulation 2009, 119:1824-1831.
264. Macia E., Boyden P.A. Stem cell therapy is proarrhythmic. Circulation 2009, 119:1814-1823.
265. Behfar A., Perez-Terzic C., Faustino R.S., et al. Cardiopoietic programming of embryonic stem cells for tumor-free heart repair. Journal of Experimental Medicine 2007, 204:405-420.
266. Gersh B.J., Simari R.D., Behfar A., et al. Cardiac cell repair therapy: A clinical perspective. Mayo Clinic Proceedings 2009, 84:876-892.
267. Aicher A., Brenner W., Zuhayra M., et al. Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation 2003, 107:2134-2139.
268. Kang H.J., Kim H.S., Zhang S.Y., et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: The MAGIC cell randomised clinical trial. Lancet 2004, 363:751-756.
269. Zohlnhofer D., Dibra A., Koppara T., et al. Stem cell mobilization by granulocyte colony-stimulating factor for myocardial recovery after acute myocardial infarction: A meta-analysis. Journal of the American College of Cardiology 2008, 51:1429-1437.
270. Fan L., Chen L., Chen X., Fu F. A meta-analysis of stem cell mobilization by granulocyte colony-stimulating factor in the treatment of acute myocardial infarction. Cardiovascular Drugs and Therapy 2008, 22:45-54.
271. Martin J.F. Stem cells and the heart: Ethics, organization and funding. Nature Clinical Practice Cardiovascular Medicine 2006, 3(supplement 1):S136-S137.